41results about How to "Inhibition of complications" patented technology

An active gastrodia soft capsule with both medical and health-care functions is composed of a core prepared from superfine active gastrodia powder extracted from gastrodia tuber, special plant oil rich in lenolenic acid (20% or more), and suspending agent, and a shell prepared from gelatin, water, glycerine and polyethanediol. Its preparing process is also disclosed.

The invention discloses an old Chenzhou fish meal seasoning. The old Chenzhou fish meal seasoning comprises the preparation raw materials in parts by weight are as follows: a sauce pack including 40 parts of palm oil, 5 parts of rapeseed oil, 10 parts of linseed oil, 5 parts of raw ginger, 5 parts of garlic, 5 parts of yellow wine, 8 parts of salt, and 10 parts of fresh fish; a powder pack including 58 parts of salt, 5 parts of white granulated sugar, 16 parts of sodium glutamate, 2.5 parts of white pepper powder, 3 parts of raw ginger powder, 4 parts of nucleotide disodium, 2 parts of youxiantai (a pure natural flavor agent), 3 parts of small chilli powder, 3 parts of pod pepper powder, 10 parts of flatfish powder, 4 parts of chive, and 1 part of red dates; and a chili oil pack including 40 parts of palm oil, 6 parts of garlic, 10 parts of red pepper powder, 1 part of star aniseed powder, 1 part of orange meal, 0.4 part of seed powder of Chinese prickly ash, 1 part of raw ginger, 20 parts of pod pepper powder, 0.5 part of semen myristicae and 0.15 part of capsanthin. The invention discloses a method for preparing the peppery chicken seasoning.

The invention discloses indole compounds having insulin-sensitizing activity, process for preparation and use, wherein the compounds and salts have the structural formula of (I), wherein R1 is hydrogen atom, substituted C1-C6 alkyl, substituted aryl alkyl, substituted aromatic heterocyclic alkyl, R2 is alkyl acyl, substituted cycloalkyl acyl, substituted aryl acyl, R3 is hydrogen atom or substituted C1-6 alkyl, R4 is hydrogen atom or substituted C1-6 alkyl, n=0, 1 or 2.

The invention relates to a veterinary medicine compound preparation for treating coccidiosis, a preparation method of the veterinary medicine compound preparation and application. The veterinary medicine compound preparation mainly consists of radix stemonae, radix sophorae flavescentis, solidago virgaurea and ethylenediamine diaceturate in a compatibility manner, is used for treating the coccidiosis, and is obvious in curative effect and not easy to cause tolerance. Raw materials are easy to be obtained. The invention further provides the preparation and the preparation method thereof. The veterinary medicine compound preparation can be prepared into granules, powder, premix, oral liquid and the like.

The invention provides a veterinary compound pure traditional Chinese medicine preparation for treating coccidium and a preparing method and application thereof. The compound traditional Chinese medicine preparation is composed of granatum, polygonum aviculare, potentilla discolor, codonopsis polosula, astragalus mongholicus, radix paeoniae alba, hawthorn and liquorice. The compound traditional Chinese medicine preparation is used for treating coccidium and is not prone to generate drug resistance. The invention further provides the preparation method and application of the compound traditional Chinese medicine preparation. The compound traditional Chinese medicine preparation can easily obtain raw materials and can be prepared into different drug forms of granula, powder, premix, oral liquid and the like.

The invention discloses an orally-taken medicine for treating fatty liver, which is composed of the following raw materials by weight: 5g to 15g rootsof Chinese thorowax, 5g to 15g nutgrass galingale rhizome, 5g to 15g finger citron, 5g to 15g danshen roots, 5g to 15g immature bitter oranges, 5g to 15g turmeric root-tubers, 5g to 15g pinellia tubers, 5g to 15g dried tangerine peels, 5g to 15g indian bread, 10g to 20g schisandra, 10g to 20g magnolia officinalis, 10g to 20g nature indigo, 10g to 20g baical skullcap roots, 10g to 20g Chinese dates and 10g to 20g hawshorn fruit. The medicine for treating fatty liver can eliminate phlegm and induce diuresis, sooth the liver, replenish qi to invigorate the spleen, warm yang to invigorate the kidney and remove blood stasis and free channels, improve the body self immunologic function, and inhibit the occurrence of complications while treating the fatty liver.

The invention discloses application of hippophae rhamnoides polysaccharide in preparing of a preparation for preventing and/or treating porcine pseudorabies virus infection. In-vitro cell experiments prove that the hippophae rhamnoides polysaccharide can effectively inhibit porcine pseudorabies virus infection and can significantly reduce cytopathy caused by porcine pseudorabies virus. The hippophae rhamnoides polysaccharide is added in different stages of virus infection, and the hippophae rhamnoides polysaccharide is found to mainly inhibit adsorption, endocytosis and replication of viruses to cells. The invention provides a safe and effective preparation with low toxic and side effects for clinically preventing and/or treating porcine pseudorabies virus infection.

The invention discloses a Chinese medicinal decoction for treating insomnia, which belongs to Chinese medicinal preparations. The Chinese medicinal decoction is characterized by comprising the following raw material medicaments by mass: 20 to 30g of data seed, 5 to 10g of danshen root, 20 to 30g of greenish lily bulb, 20 to 30g of dried longan pulp and 20 to 30g of thinleaf milkwort root-bark. The Chinese medicinal decoction has the advantages of simple formula components, convenient processing and use, short course of treatment, quick response and no relapse.

The invention relates to a composition for reducing blood glucose and blood lipid and preventing and/or treating diabetes mellitus and complications thereof and application of the composition. The composition in a formula comprises, by weight, 20%-75% of herba houttuyniae, 15%-70% of prunus persica and 10%-30% of cortex phellodendri. The composition and the application have the advantages that good curative effects can be realized by the composition for preventing and treating the diabetes mellitus, type 2 diabetes mellitus in particular, high blood lipid and the diabetes complications, and side effects rarely can be realized; the composition can be used for preparing medicines for reducing the blood glucose and the blood lipid and preventing and/or treating the diabetes mellitus and the complications of the diabetes mellitus and also can be used for preparing healthcare products for reducing the blood glucose and the blood lipid and preventing the diabetes mellitus and the complications of the diabetes mellitus.

Provided is a composition for treating and preventing diabetes or diabetic complications comprising an extract of herbal combination as an effective ingredient. The composition for treating and preventing diabetes or diabetic complications includes an extract of herbal combination of bitter melon, caterpillar fungus, wolfberry tree bark, white mulberry bark, winged euonymus, kudzu root, Solomon's seal, white atractylodes rhizome, mondo grass rhizome, Japanese cornel fruit and ginseng as an effective ingredient. The composition increases secretion of insulin in a type 2 diabetic animal, improves insulin resistance and exhibits potent blood sugar-lowering and diabetic complication inhibiting activities. Further, since it is safe with natural product ingredients, it may be usefully used to prevent and improve diabetic diseases and inhibit diabetic complications.

The invention discloses anti-cancer and hemostatic Chinese patent drug which comprises the following components by weight: 150 to 200 parts of salsola-like inula flower and herb, 100 parts of white atractylodes rhizome, 100 parts of zedoary, 100 parts of Chinese angelica root, 100 parts of psoralea fruit, 100 parts of pinellia tuber, 100 parts of fritillary bulb, 100 parts of asarum sagittarioides, 60 parts of ginseng, 40 parts of American ginseng, 50 parts of astragalus root, 50 parts of white peony root, 30 parts of rhizome of Sichuan lovage, 50 parts of ass-hide glue, 50 parts of bark of chinese cassia tree, 40 parts of Mabuzi, 7 parts of Banmo, 3 parts of arenobufagin and 40 parts of borneol. The Chinese patent drug has the effects that the curative effect is quick, the Chinese patent drug can effectively restrain complications, is broad-spectrum and anti-cancer, safe, reliable, short in course of treatment, and overcomes the problem of the multidrug resistance of cancer cells, patients can not suffer a relapse after being healed, and the Chinese patent drug has the function of improving the medullary hematopoiesis.

The invention discloses a pharmaceutical composition for treating II-type diabetes and a preparation method of pharmaceutical composition. The pharmaceutical composition comprises the following ingredients in parts by weight: 80-150 parts of a crude fiber mixture, 60-90 parts of phycocyanobilin, 50-80 parts of patuletin, 38-76 parts of diosgenin, 35-70 parts of rutin, 16-30 parts of polyethylene glycol, 15-24 parts of pyridoxine, 12-18 parts of flavonoid glycosides, 10-16 parts of linoleic acid, 10-15 parts of sciadopitysin, 8-13 parts of kaempferol, 8-12 parts of quercetin, 7-11 parts of glutamic acid, 6-10 parts of lysine, 5-10 parts of tannin, 5-8 parts of flunarizine, 4-7 parts of thiamine and 2-6 parts of mixed enzyme. The pharmaceutical composition disclosed by the invention is a combination of traditional Chinese medicine and western medicines, effectively reduces the blood sugar and improves the glucose tolerance level of a muscle body on the basis of regulating the normal diet, regulates various abnormal indicators of the muscle body, enhances the tolerance of long-term drug use of a diabetic patient and reduces drug side effects. The pharmaceutical composition disclosed by the invention is simple in preparation process and convenient to use and has good clinical popularization significance.

The invention provides ganoderma lucidum black propolis. The ganoderma lucidum black propolis is prepared from black propolis cream, buckwheat honey and natural ganoderma lucidum. A preparation method of the ganoderma lucidum black propolis comprises the steps that 1, black propolis cream collected by big black bees is taken to be put into a stainless steel container and mixed with alcohol, the black propolis cream is soaked and dissolved to be black paste, the mixing amount of the alcohol meets the condition that the propolis cream can be submerged, and the alcohol is filtered out and recycled after the black propolis cream is changed into black paste; 2, natural ganoderma lucidum is washed clean for removing dirt, leached, baked by containing water, dried and crushed into powder for standby application; 3, the buckwheat honey is filtered to remove impurities, and evaporation and concentration are performed through a traditional method; 4, the black paste propolis cream, the standby powder and the concentrated honey are stirred and mixed to be uniform, and then the ganoderma lucidum black propolis is obtained. The ganoderma lucidum black propolis has the effects of killing bacteria, expelling toxin, dredging the blood vessels, lowering the blood lipid and preventing cardiovascular and cerebrovascular diseases and has the effect of inhibiting diabetic complications.

The invention provides salicylic acid compounds with a structure shown as the following formula (I). In the formula (I), R1 refers to substituted alkyl having 1 to 6 carbon atoms, substituted aryl alkyl, or substituted aromatic heterocyclic alkyl; R2 refers to ethyl or acetyl; and R3 refers to hydrogen atom or methyl. The invention also provides two preparation methods for the salicylic acid compounds with the structure of the formula (I). The salicylic acid compounds have insulin-sensitizing activity.

The invention discloses plateau opuntia ficus-indica lozenges. The plateau opuntia ficus-indica lozenges are green and nutritional dietary foods which are developed and refined by using edible and medicinal plant raw materials, including natural opuntia ficus-indica which grows in 1800-meter high mountains, plateau jerusalem artichoke, chicory and so on; and the plateau opuntia ficus-indica lozenges are rich in plant polysaccharide compounds. The plateau opuntia ficus-indica lozenges have enhanced and improved nourishing diet health-care effects to the patients with the type-II diabetes, and are beneficial for improving healthy living standards of the diabetic patients. The plateau opuntia ficus-indica lozenges are prepared from the following raw materials: 40-50 parts of plateau opuntia ficus-indica, 15-20 parts of jerusalem artichoke, 10-15 parts of chicory, 8-12 parts of kudzu-vine roots, 5-10 parts of stevia rebaudiana bertoni and 2-3 parts of liquorice roots. The synergistic reactions of the plateau opuntia ficus-indica and the Chinese herbal medicines are utilized so as to effectively improve the nourishing and health-caring functions of the lozenges. Moreover, the prepared plateau opuntia ficus-indica lozenges are safe, free of side effects and convenient to eat, and have relatively good market application prospects.

The invention discloses a health care product for reducing blood glucose and blood fat and a preparation method of the health care product. The health care product comprises 290-300 parts of onion freeze-dried powder, 82-88 parts of bitter melon extracts, 20-28 parts of ginkgo leaf extracts, 90-96 parts of mulberry leaf extracts and 4-7 parts of magnesium stearate. The preparation method of the health care product includes the steps: firstly, crushing the onion freeze-dried powder, the bitter melon extracts, the ginkgo leaf extracts and the mulberry leaf extracts, and sieving crushed materialsby a screen with 80-100 meshes to obtain fine raw material powder; secondly, mixing the fine raw material powder for 20-30 min, humidifying the mixed raw material powder to obtain mixed materials, and sieving the mixed materials by a 20-mesh screen to obtain wet particles; thirdly, performing boiling and drying on the wet particles, adding the magnesium stearate, uniformly mixing mixture, sievingthe mixture by a 18-mesh screen to obtain dry particles, and performing filling with the dry particles to form capsules to obtain the health care product for reducing the blood glucose and the bloodfat. The acquired health care product can remarkably improve health conditions of diabetes mellitus and high-blood-fat people and can also prevent diabetes mellitus and high-blood-fat diseases for common people.

The invention provides a traditional Chinese medicine tablet for treating diabetes and a preparing method thereof and relates to the technical field of treatment of diabetes. The traditional Chinese medicine tablet mainly aims to solve the problem that it is difficult to restrain subsequent complications while the diabetes is treated. The effective ingredients of raw material medicine for making the tablet comprises, by mass, 20-35 parts of gallnut, 9-21 parts of mulberries, 14-28 parts of bitter gourd, 10-25 parts of guava, 6-18 parts of rhizome of rehmannia, 17-29 parts of glossy privet fruits, 8-26 parts of radix polygonati officinalis, 10-21 parts of radix asparagi, 7-22 parts of plaster stone, 12-27 parts of poria cocos, 10-24 parts of cortex lycii radicis, 15-35 parts of honeysuckle, 5-25 parts of pipewort, 10-30 parts of Chinese yam, 5-25 parts of citron peel, 8-26 parts of mangnolia officinalis, 17-31 parts of roots of common peony, 7-22 parts of herba lycopi, 10-25 parts of winged euonymus twigs and 12-27 parts of rhizoma sparganii. By means of the traditional Chinese medicine tablet, treatment of the diabetes can be promoted, and the total treatment effective rate reaches over 98%.

The invention discloses a plateau pome lozenge for treating diabetes. The plateau pome lozenge comprises the following raw materials in percent by weight: 35-40% of cactus, 10-15% of poria cocos, 10-15% of Chinese yam, 5-10% of inulin and 25-35% of kudzu vine root. Compared with the prior art, the plateau pome lozenge has the advantages as follows: through reasonable and scientific selection of the raw materials, namely the cactus, the poria cocos, the Chinese yam, the inulin and the kudzu vine root, and the proportions thereof, the plateau pome lozenge is rich in superoxide dismutase SOD, plant polysaccharide and soluble dietary fiber; under the comprehensive action of the raw materials, the plateau pome lozenge enhances the body immunity while the blood sugar is reduced and the diabetes is prevented and treated, and can effectively inhibit diabetic complications.

The invention discloses an application of a benzimidazole compound in preparation of anti-hepatitis B virus drugs. The benzimidazole compound is a novel nucleocapsid inhibitor, and can effectively inhibit assembly of hepatitis B virus core protein and replication of hepatitis B virus. The benzimidazole compound provided by the invention has a wide application prospect in the preparation of anti-HBV drugs and drugs for treating hepatitis B virus infection related diseases, solves the problem that effective anti-HBV drugs are urgently needed at present, and provides a new application of the benzimidazole compound in the anti-HBV drugs.

The invention relates to a solid pharmaceutical composition containing metformin and vildagliptin. The solid pharmaceutical composition containing metformin and vildagliptin comprises the following components in parts by mass: 1-3 parts of the metformin, 15-60 parts of the vildagliptin, 1-3 parts of rosiglitazone and 0.8-2 parts of vitamin B. The solid pharmaceutical composition containing metformin and vildagliptin is a single tablet or a capsule. According to the solid pharmaceutical composition containing metformin and vildagliptin, through scientific combination of three different hypoglycemic drugs, the purposes of mechanism complementation, mutual cooperation, curative effect improvement and reasonable medication are achieved.